Posted On: 12/12/2013 8:43:31 AM
Post# of 63741
$NVLX Acquisition of Cellulose-based Live-Cell Encapsulation Technology Positions Company as a Leader in Development of Next Generation Cancer and Diabetes Treatments
http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U
(0)
(0)Scroll down for more posts ▼
